0001104659-19-075322.txt : 20191223 0001104659-19-075322.hdr.sgml : 20191223 20191223083423 ACCESSION NUMBER: 0001104659-19-075322 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191220 FILED AS OF DATE: 20191223 DATE AS OF CHANGE: 20191223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DAVIS RICHARD E CENTRAL INDEX KEY: 0001245310 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-54986 FILM NUMBER: 191303507 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Arch Therapeutics, Inc. CENTRAL INDEX KEY: 0001537561 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 460524102 STATE OF INCORPORATION: NV FISCAL YEAR END: 0930 BUSINESS ADDRESS: STREET 1: 235 WALNUT STREET, SUITE 6 CITY: FRAMINGHAM STATE: MA ZIP: 01702 BUSINESS PHONE: 617-431-2313 MAIL ADDRESS: STREET 1: 235 WALNUT STREET, SUITE 6 CITY: FRAMINGHAM STATE: MA ZIP: 01702 FORMER COMPANY: FORMER CONFORMED NAME: ALMAH,INC DATE OF NAME CHANGE: 20111216 4 1 tm1926824-4_4.xml FORM 4 X0306 4 2019-12-20 0 0001537561 Arch Therapeutics, Inc. ARTH 0001245310 DAVIS RICHARD E C/O ARCH THERAPEUTICS, INC. 235 WALNUT STREET, SUITE 6 FRAMINGHAM MA 01702 0 1 0 0 CFO & Treasurer Stock Option (right to buy) 0.2292 2019-12-20 4 A 0 700000 0 A 2029-12-19 Common Stock 700000 700000 D The Shares subject to the Option, 25% shall vest immediately and 1/36 of the remaining shares shall vest on each of the next thirty-six (36) monthly anniversaries of the commencement date. Such shares will remain exercisable for 365 days after written notice of termination by either party. In the event of a Change of Control (as such term is defined in the Plan) all Options subject to this grant will immediately vest. /s/ Richard E. Davis 2019-12-23